Italy's Rottapharm pulls plug on IPO on worsening market conditions
MILAN, July 10
MILAN, July 10 (Reuters) - Italian pharmaceauticals company Rottapharm Madaus (IPO-ROTT.MI) on Thursday said it has pulled plans for its initial public offfering (IPO) due to adverse market conditions and souring investor sentiment on southern European assets, it said.
It had been planning to usse 50 million shares, or 25 percent of its capital, at a price of 7.25-9 euros per share.
(Reporting by Oleg Vukmanovic)